Medtronic PLC (N:MDT)

Business Focus: Medical Equipment, Supplies & Distribution

Mar 27, 2024 04:17 pm ET
Orchestra BioMed Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today reported its full year 2023 financial...
Mar 27, 2024 09:00 am ET
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market Growth
FN Media Group News Commentary - Artificial intelligence (AI) in the healthcare market is highly competitive due to a significant number of players operating in the domestic and international markets. Due to the increase in the applications of AI...
Mar 27, 2024 08:00 am ET
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
Mar 27, 2024 08:00 am ET
Medtronic announces FDA approval of newest-generation Evolut TAVR system for treatment of symptomatic severe aortic stenosis
The Evolut™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
Mar 21, 2024 02:51 pm ET
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Medtronic moves for patent infringement litigation to resume
Mar 21, 2024 02:51 pm ET
U.S. Patent Office rejects Axonics' latest challenge to Medtronic patents
Medtronic moves for patent infringement litigation to resume
Mar 13, 2024 08:00 am ET
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy Presentations at CRT 2024 Annual Meeting
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced two oral presentations were given...
Mar 05, 2024 03:30 pm ET
Medtronic EVP & CFO Karen Parkhill to participate in the Barclays healthcare conference
DUBLIN, March 5, 2024 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 26th annual Barclays global healthcare conference on Tuesday, March 12, 2024.
Mar 04, 2024 03:50 pm ET
Medtronic Once Again Named One of the World's Most Ethical Companies
Annual list highlights organizations leading the way in business integrity
Feb 26, 2024 08:00 am ET
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambulatory Systolic Blood Pressure in Hypertensive Pacemaker Patients Treated with AVIM Therapy for Over
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the presentation of new data...
Feb 21, 2024 09:15 am ET
Upfront Tuition Coverage Is a Game-Changer for Medtronic Employees
MAPS program helped remove barriers to education; Candi Sneed becomes first link in a chain of future engineers
Feb 20, 2024 05:45 am ET
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance
Feb 20, 2024 05:45 am ET
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance
Feb 20, 2024 03:00 am ET
Medical Technology Stocks to Keep On The Radar
The healthcare technology industry is one that offers investors a plethora of opportunities. With global healthcare spending soaring to approximately $8.3 trillion and nearly half of that amount allocated in the U.S. alone, the sector presents intriguing growth prospects. As the healthcare industry outpaces the overall global economy in growth, investors find themselves on the cusp of a promising market.
Feb 07, 2024 12:45 pm ET
Grounding in Healing To Navigate the DEI Landscape in 2024
NORTHAMPTON, MA / ACCESSWIRE / February 7, 2024 / Medtronic
Feb 06, 2024 11:00 am ET
Medtronic: Green Flags To Look For in ID&E Reporting
When it comes to inclusion, diversity, and equity reporting - not all reports are created equal
Feb 06, 2024 06:15 am ET
Medtronic to announce financial results for its third quarter of fiscal year 2024
DUBLIN, Feb. 6, 2024 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2024 on Tuesday, February 20, 2024. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2024, which ended on Friday, January 26, 2024.
Feb 06, 2024 06:15 am ET
Medtronic to announce financial results for its third quarter of fiscal year 2024
DUBLIN, Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2024 on Tuesday, February 20, 2024. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2024, which ended on Friday, January 26, 2024.
Feb 05, 2024 09:50 am ET
Medtronic Named One of America's Most JUST Companies
The JUST 100 is the only ranking that recognizes American corporate leadership on business issues prioritized by the public
Jan 22, 2024 12:45 pm ET
Medtronic: Here Comes the Sun - 3 Things To Know About Our Solar Footprint
Our commitment to investing in renewable energy forms like solar is a bright idea in our sustainability toolkit
Jan 16, 2024 11:00 am ET
Medtronic LABS President Ruchika Singhal Named “Corporate Social Innovator of the Year” by Schwab Foundation
Since its inception, LABS has screened 1.6 million patients, enrolled more than 237,000 people in healthcare programs, and improved more than 100,000 lives
Jan 08, 2024 11:38 am ET
FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology
Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming.
Jan 08, 2024 07:30 am ET
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pacemaker Patients
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the first patient was randomized...
Jan 08, 2024 05:45 am ET
Medtronic Diabetes announces world's first approval for MiniMed™ 780G System with Simplera Sync™ disposable, all-in-one sensor
With CE Mark approval, the benefits of the MiniMed™ 780G system are now available with a new sensor that takes less than 10 seconds to insert1
Jan 05, 2024 05:45 am ET
Medtronic receives CE Mark for its next generation Micra leadless pacing systems
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership
Dec 18, 2023 04:35 pm ET
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
DUBLIN, Dec. 18, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 42nd annual J.P. Morgan healthcare conference on Monday, January 8, 2024.
Dec 18, 2023 04:35 pm ET
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
DUBLIN, Dec. 18, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 42nd annual J.P. Morgan healthcare conference on Monday, January 8, 2024.
Dec 15, 2023 11:00 am ET
Medtronic Continues To Rank in the DJSI World Index for 2023
NORTHAMPTON, MA / ACCESSWIRE / December 15, 2023 / Medtronic
Dec 13, 2023 05:03 pm ET
Medtronic creates history with FDA approval of its novel PulseSelect™ Pulsed Field Ablation System to treat atrial fibrillation
Safe, efficient, and effective treatment for both paroxysmal and persistent atrial fibrillation
Dec 11, 2023 12:00 am ET
Medtronic and Cosmo Pharmaceuticals forge ahead in AI-driven care
Agreement expands partnership between Medtronic and Cosmo Pharmaceuticals, set to transform endoscopy with cutting-edge AI technology
Dec 07, 2023 03:17 pm ET
Medtronic announces cash dividend for third quarter of fiscal year 2024
DUBLIN, Dec. 7, 2023 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 7, 2023, approved the company's cash dividend for the third quarter of fiscal year 2024 of $0.69 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2023. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 46 consecutive years. The dividend is payable on January 12, 2024, to shareholders of record at the close of business on Dece
Dec 05, 2023 09:15 am ET
Medtronic LABS: The Vital Role Of Community Health Workers
NORTHAMPTON, MA / ACCESSWIRE / December 5, 2023 / Medtronic
Dec 01, 2023 12:15 pm ET
Medtronic Earns Equality 100 Award for LGBTQ+ Workplace Inclusion
Human Rights Campaign Foundation recognizes the company's ongoing commitment to inclusion, diversity, and equity
Nov 28, 2023 11:30 am ET
Medtronic LABS: Opening Up Software To Expand Access to Healthcare
NORTHAMPTON, MA / ACCESSWIRE / November 28, 2023 / Medtronic
Nov 22, 2023 08:31 am ET
Thinking about trading options or stock in Medtronic, Applied Materials, Autolus Therapeutics, Bright Minds Biosciences, or Tremor International?
NEW YORK, Nov. 22, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MDT, AMAT, AUTL, DRUG, and TRMR.
Nov 21, 2023 05:45 am ET
Medtronic reports second quarter fiscal 2024 financial results
Solid execution results in mid-single digit revenue growth, driven by broad-based strength across multiple businesses and geographies; Major innovative product approvals; Raises fiscal year guidance
Nov 17, 2023 05:30 pm ET
Medtronic announces FDA approval of minimally invasive device to treat hypertension
The Symplicity™ blood pressure procedure offers patients a new adjunct approach to lowering blood pressure
Nov 14, 2023 05:30 pm ET
Medtronic: A Majority of Americans Are Optimistic That AI Will Improve Healthcare in 2024
According to a new survey from Medtronic and Morning Consult, respondents recognize potential of AI to enable earlier diagnosis and improve access to care
Nov 13, 2023 07:08 am ET
A majority of Americans are optimistic that AI will improve healthcare in 2024
According to a new survey from Medtronic and Morning Consult, respondents recognize potential of AI to enable earlier diagnosis and improve access to care
Nov 08, 2023 01:00 pm ET
Bridging the Hearing Care Gap in Bhutan
Medtronic LABS joined forces with the Ministry of Health, Royal Government of Bhutan, ADA, The United Nations Technology Bank, MED-EL, and others to revolutionize pediatric ear and hearing care in Bhutan
Nov 07, 2023 06:50 am ET
Medtronic to announce financial results for its second quarter of fiscal year 2024
DUBLIN, Nov. 7, 2023 /CNW/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2024 on Tuesday, November 21, 2023. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2024, which ended on Friday, October 27, 2023.
Nov 07, 2023 06:50 am ET
Medtronic to announce financial results for its second quarter of fiscal year 2024
DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2024 on Tuesday, November 21, 2023. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2024, which ended on Friday, October 27, 2023.
Nov 03, 2023 12:20 pm ET
Medtronic: Helping Lead the Way in Packaging Waste Reduction
NORTHAMPTON, MA / ACCESSWIRE / November 3, 2023 / Medtronic:
Nov 02, 2023 03:40 pm ET
Medtronic Wins U.S. Chamber of Commerce Foundation 2023 Citizens Award
NORTHAMPTON, MA / ACCESSWIRE / November 2, 2023 / Medtronic
Oct 25, 2023 12:05 pm ET
Medtronic LABS: SPICE Named Digital Public Good
NORTHAMPTON, MA / ACCESSWIRE / October 25, 2023 / Medtronic:
Oct 24, 2023 02:22 pm ET
Medtronic Evolut™ TAVR platform outperforms surgery with sustained valve performance for low-risk patients at four years
TCT 2023: Medtronic adds to the body of evidence for Evolut TAVR with late-breaking clinical trial data from the Evolut Low Risk Trial
Oct 23, 2023 08:00 am ET
Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest
First-of-its-kind Aurora EV-ICD™ system offers single device, single procedure with lead placed outside of heart and veins
Oct 18, 2023 10:30 am ET
Medtronic Named to 100 Best Corporate Citizens of 2023
This is the 7th year in a row that Medtronic has been named to the list, jumping to #17 in 2023.
Oct 17, 2023 01:35 pm ET
Medtronic Earns Four 5-Star Ratings From the Hispanic Association on Corporate Responsibility
Medtronic is one of only three companies to achieve top scores in all four pillars
Oct 11, 2023 12:15 pm ET
Transparency, Accountability, Commitment: Three Non-Negotiables for Responsible Business
Executives are faced with a tremendous obligation - to employees, communities, and shareholders - and an unparalleled opportunity.
Oct 10, 2023 01:00 pm ET
Medtronic: Building a More Sustainable Future
Stories from our latest Sustainability Report
Oct 03, 2023 09:15 am ET
TMCF and Medtronic Partner To Launch Academic R&D Grants at HBCUs
Thurgood Marshall College Fund and Medtronic partner to launch the Research & Development Engagement program
Oct 02, 2023 08:00 am ET
Gentherm Announces Dr. Ken Washington as New Independent Director
Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced that Dr. Ken...
Sep 21, 2023 07:00 am ET
Medtronic Diabetes announces CE Mark for new Simplera™ CGM with disposable all-in-one design
The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience
Sep 19, 2023 01:45 pm ET
Medtronic LABS Unveils Commitment To Scale Tech-Enabled Healthcare at Clinton Global Initiative 2023 Meeting
The commitment will form a consortium that brings together cross-sector partners to scale community-based, tech-enabled solutions for underserved patients, families, and communities across the world.
Sep 19, 2023 07:30 am ET
Orchestra BioMed Granted FDA Approval of IDE to Initiate BACKBEAT Pivotal Study of BackBeat CNT™ for the Treatment of Hypertension in Pacemaker Patients
Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced the U.S. Food and Drug...
Aug 31, 2023 06:05 pm ET
Medtronic Foundation: 3 Ways To Transform Corporate Volunteering
NORTHAMPTON, MA / ACCESSWIRE / August 31, 2023 / Medtronic
Aug 22, 2023 06:16 pm ET
Medtronic to participate in upcoming investor conferences
DUBLIN, Aug. 22, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today confirmed its participation in the following upcoming investor conferences:
Aug 17, 2023 12:15 pm ET
Over 3.3M Meals Packed by Medtronic Employee Volunteers
NORTHAMPTON, MA / ACCESSWIRE / August 17, 2023 / Medtronic employees are dedicated to helping others through volunteering and community engagement beyond their daily jobs. As part of the annual Medtronic volunteering drive, employees in Minneapolis packed 98,700 meals in just two days this summer - contributing to over 3.3M meals packed by Medtronic employees in partnership with Meals From The Heart. The meals are distributed to local food shelves.
Aug 10, 2023 01:00 pm ET
Medtronic Mobile Labs Head to College
NORTHAMPTON, MA / ACCESSWIRE / August 10, 2023 / Medtronic:
Aug 08, 2023 11:23 am ET
Medtronic to announce financial results for its first quarter of fiscal year 2024
DUBLIN, Aug. 8, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its first quarter of fiscal year 2024 on Tuesday, August 22, 2023. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's first quarter of fiscal year 2024, which ended on Friday, July 28, 2023.
Aug 02, 2023 09:00 am ET
Medtronic: How Lake Geneva Helps Heat and Cool a European Manufacturing Site
NORTHAMPTON, MA / ACCESSWIRE / August 2, 2023 / As the Medtronic Switzerland campus expanded in 2001 and again in 2009, its oil-fired heating and cooling equipment became obsolete and needed replacement.
Jul 11, 2023 09:10 am ET
Medtronic Recognized as a "Best Place To Work for Disability Inclusion"
NORTHAMPTON, MA / ACCESSWIRE / July 11, 2023 / For the sixth consecutive year, Medtronic is recognized as a "Best Place to Work for Disability Inclusion" by Disability:IN and the American Association of People with Disabilities. This honor is the result of Medtronic earning a top score of 100 on the 2023 Disability Equality Index®, which is the world's most comprehensive benchmarking tool for measuring disability workplace inclusion.
Jun 26, 2023 04:45 pm ET
Medtronic: By the Community, for the Community
NORTHAMPTON, MA / ACCESSWIRE / June 26, 2023 / When Olwi Abzueta learned a school in her community in the Dominican Republic (DR) needed help, she knew she couldn't turn down the opportunity to make a difference.
Jun 26, 2023 07:00 am ET
Medtronic Board appoints Greg Lewis as new Director
DUBLIN, June 26, 2023 /PRNewswire/ -- Medtronic announced today that its Board of Directors appointed Greg Lewis, Senior Vice President and Chief Financial Officer at Honeywell, to the Board. Lewis will serve on the Audit Committee and the Finance and Financial Risk Committee, effective June 26, 2023.
Jun 23, 2023 09:30 pm ET
Medtronic presents new data on MiniMed™ 780G system on fixed meal dosing and real-world Time in Range across wide variety of users
DUBLIN and SAN DIEGO, June 23, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a robust collection of new clinical and real-world data on the MiniMed™ 780G system. These latest data sets, which evaluated the system across a wide range of users, including historically challenging younger patients, those not meeting glycemic goals, and individuals using a simplified meal announcement leveraging fixed carbohydrate amounts instead of exact carb calculations, found that the proprietary Meal Detection™ technology supported Time in Range outco
Jun 20, 2023 04:50 pm ET
Recipe for Bonding: Paid Leave Gives New Dad Needed Time
NORTHAMPTON, MA / ACCESSWIRE / June 20, 2023 / When Todd Gillenwater and his wife adopted two children from Bulgaria, there was a lot to learn - from the kids' favorite foods to how to help them acclimate to life in the U.S.
Jun 15, 2023 01:25 pm ET
Everstream Analytics & Medtronic Recognized by Supply & Demand Chain Executive
NORTHAMPTON, MA / ACCESSWIRE / June 15, 2023 / Medtronic
Jun 12, 2023 09:00 am ET
Medtronic to present new data on its intelligent dosing platforms at the American Diabetes Association 83rd Scientific Sessions
DUBLIN, June 12, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced its participation in the upcoming American Diabetes Association's (ADA) 83rd Scientific Sessions in San Diego on Jun. 23-26, 2023. During the conference, Medtronic will present new data and clinical outcomes across a broad population of patients from its newly FDA-approved MiniMed™ 780G system with Guardian™ 4 sensor — which began shipping in the U.S. earlier this month — as well as their Extended Infusion Set and InPen™ smart insulin pen.
Jun 01, 2023 04:30 pm ET
Medtronic names Ken Washington new Chief Technology and Innovation Officer
DUBLIN, June 1, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced that Ken Washington, Ph.D., has been appointed Medtronic Chief Technology and Innovation Officer. In this newly created role, Dr. Washington will leverage his extensive experience leading technology development and execution across industries including robotics, consumer products, automotive, and space, to accelerate innovation-driven growth in service of the company's mission to alleviate pain, restore health and extend life. Dr. Washington will also become a member of the Medtronic Executive Committee. 
May 30, 2023 07:45 am ET
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
DUBLIN, May 30, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare conference on Monday, June 12, 2023.
May 30, 2023 07:45 am ET
Medtronic chairman and CEO Geoff Martha to speak at Goldman Sachs global healthcare conference
DUBLIN, May 30, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 44th annual Goldman Sachs global healthcare conference on Monday, June 12, 2023.
May 25, 2023 06:46 am ET
Medtronic to acquire wearable insulin patch maker EOFlow
Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support
May 25, 2023 06:46 am ET
Medtronic to acquire wearable insulin patch maker EOFlow
Acquisition will expand company's ability to serve more people living with diabetes around the world within one seamless Medtronic ecosystem of support
May 25, 2023 06:45 am ET
Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase
Mid-single digit fourth quarter revenue growth exceeded expectations on broad-based strength across the company
May 25, 2023 06:45 am ET
Medtronic reports full year and fourth quarter fiscal 2023 financial results; announces dividend increase
Mid-single digit fourth quarter revenue growth exceeded expectations on broad-based strength across the company
May 20, 2023 04:45 pm ET
Medtronic Extravascular ICD global clinical trial results reinforce device safety and effectiveness
Late-breaking data at Heart Rhythm 2023 underscore performance of first-of-its-kind investigational defibrillator with the lead placed under the breastbone, outside the heart and veins
May 19, 2023 01:00 pm ET
Medtronic Designated as a "3+" Company in the 50/50 Women on Boards Gender Diversity Directory(TM)
NORTHAMPTON, MA / ACCESSWIRE / May 19, 2023 / Medtronic is now designated as a "3+" company in the 50/50 Women on Boards Gender Diversity Directory™.
May 18, 2023 06:20 pm ET
How One Leader Is Aiming Higher To Increase Asian American Representation
NORTHAMPTON, MA / ACCESSWIRE / May 18, 2023 / Medtronic
May 16, 2023 10:00 am ET
Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution
AccuRhythm AI algorithms now cleared by FDA for the Reveal LINQ ICM; enhancements made to the AF algorithm for the LINQ II ICM 
May 11, 2023 08:45 am ET
Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
DUBLIN, May 11, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2023 on Thursday, May 25, 2023. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2023, which ended on Friday, April 28, 2023.
May 11, 2023 08:45 am ET
Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
DUBLIN, May 11, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its fourth quarter and full fiscal year 2023 on Thursday, May 25, 2023. A news release will be issued at approximately 5:45 a.m. Central Daylight Time (CDT) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's fourth quarter and full fiscal year 2023, which ended on Friday, April 28, 2023.
May 03, 2023 01:15 pm ET
Medtronic Jumps to No. 2 in DiversityInc Top 50 Companies List
NORTHAMPTON, MA / ACCESSWIRE / May 3, 2023 / Medtronic climbed to No. 2 on DiversityInc's 2023 Top 50 Companies for Diversity, up 8 spots from last year's ranking of 10. This is our highest-ever ranking on the prestigious list.
May 02, 2023 03:45 pm ET
Medtronic LABS Work Honored As World Changing by Fast Company
NORTHAMPTON, MA / ACCESSWIRE / May 2, 2023 / Medtronic
May 01, 2023 09:32 am ET
Medtronic receives FDA approval for its next generation Micra leadless pacing systems
New pacemakers offer 40% more battery life,1 extend Medtronic legacy of pacing leadership
Apr 25, 2023 04:30 pm ET
Medtronic Diabetes resolves warning letter, clearing path for future innovations
Resolution follows the recent FDA approval of the MiniMed™ 780G system featuring the world's first and only automated insulin delivery system with real-time meal detection technology*
Apr 21, 2023 04:58 pm ET
FDA Approves Medtronic MiniMed™ 780G System - World's First Insulin Pump with Meal Detection Technology* Featuring 5-Minute Auto Corrections†§
Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps
Apr 12, 2023 01:45 pm ET
Building Stronger Businesses – Together
NORTHAMPTON, MA / ACCESSWIRE / April 12, 2023 / Tiny parts like precision mechanical springs and wire forms bring many of the innovative devices at Medtronic to life. And we care about where they come from - both from a quality and a community standpoint.
Apr 07, 2023 08:15 am ET
Medtronic LABS' Broader Scope Expands Access
NORTHAMPTON, MA / ACCESSWIRE / April 7, 2023 / Medtronic:
Apr 06, 2023 01:15 pm ET
Connecting the Dots - For Community
Volunteer Appreciation Month takes place every year in April and celebrates the impact volunteers have on our lives and encourages active volunteerism for generations to come. The Medtronic Foundation is committed to supporting communities where Medtronic employees live and give by providing resources that support volunteerism and giving across the globe.
Apr 01, 2023 12:00 pm ET
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
New, independent kidney health technology company will combine expertise from two industry leaders to drive care transformation
Apr 01, 2023 12:00 pm ET
Medtronic, DaVita launch Mozarc Medical, aimed at introducing new solutions for patients with kidney failure
New, independent kidney health technology company will combine expertise from two industry leaders to drive care transformation
Mar 27, 2023 09:15 am ET
Medtronic: Karen Parkhill on Empowering Women, Business Transformation
NORTHAMPTON, MA / ACCESSWIRE / March 27, 2023 / In her six years as chief financial officer at Medtronic, Karen Parkhill has helped advance women's representation at all levels of the company.
Mar 23, 2023 07:41 pm ET
Medtronic Announces Pricing of $2.0 Billion of Senior Notes
DUBLIN, March 23, 2023 /CNW/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering (the "Offering") of $1,000,000,000 principal amount of 4.25% senior notes due 2028 and $1,000,000,000 principal amount of 4.50% senior notes due 2033 (collectively, the "Notes").  All of Medtronic Luxco's obligations under the Notes will be fully and unconditionally guaranteed by the Company and Medtronic, Inc., a wholly-owned indirect subsidiary of Medtronic Luxco, on a senior unsecured basis.
Mar 23, 2023 07:41 pm ET
Medtronic Announces Pricing of $2.0 Billion of Senior Notes
DUBLIN, March 23, 2023 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering (the "Offering") of $1,000,000,000 principal amount of 4.25% senior notes due 2028 and $1,000,000,000 principal amount of 4.50% senior notes due 2033 (collectively, the "Notes").  All of Medtronic Luxco's obligations under the Notes will be fully and unconditionally guaranteed by the Company and Medtronic, Inc., a wholly-owned indirect subsidiary of Medtronic Luxco, on a senior unsecured
Mar 22, 2023 11:15 am ET
Medtronic to boost AI innovation with new platform introduction
A strategic collaboration with Cosmo Pharmaceuticals  and NVIDIA delivers the GI Genius™ AI Access™ platform designed to accelerate AI innovation for healthcare.
Mar 22, 2023 11:15 am ET
Medtronic to boost AI innovation with new platform introduction
A strategic collaboration with Cosmo Pharmaceuticals  and NVIDIA delivers the GI Genius™ AI Access™ platform designed to accelerate AI innovation for healthcare.
Mar 15, 2023 08:00 am ET
Medtronic receives CE Mark approval for Affera™ Mapping and Ablation System to treat atrial arrhythmias
First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform
Mar 15, 2023 08:00 am ET
Medtronic receives CE Mark approval for Affera™ Mapping and Ablation System to treat atrial arrhythmias
First of its kind, all-in-one Sphere-9™ Catheter with pulsed field ablation, radiofrequency, and high density mapping integrated with intuitive mapping and navigation platform
Mar 13, 2023 09:00 am ET
Medtronic named one of World's Most Ethical Companies
Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices
Mar 13, 2023 09:00 am ET
Medtronic named one of World's Most Ethical Companies
Recognition honors companies demonstrating business integrity through best-in-class ethics, compliance, and governance practices
Mar 06, 2023 08:30 am ET
Medtronic PulseSelect PFA System demonstrates impressive results in landmark PULSED AF global IDE trial
ACC.23/WCC late-breaking data: PULSED AF, one of the most rigorously executed PFA clinical studies to date, exceeds safety and efficacy performance goals in the treatment of paroxysmal and persistent atrial fibrillation
Mar 02, 2023 03:30 pm ET
Medtronic Announces Cash Dividend for Fourth Quarter of Fiscal Year 2023
DUBLIN, March 2, 2023 /CNW/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, March 2, 2023, approved the fiscal year 2023 fourth quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 45 consecutive years. The dividend is payable on April 14, 2023, to shareholders of record at the close of busines
Feb 27, 2023 12:00 pm ET
Medtronic Executive Vice President and CFO Karen Parkhill to speak at Cowen healthcare conference
DUBLIN, Feb. 27, 2023 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual Cowen healthcare conference on Monday, March 6, 2023.
Feb 24, 2023 10:00 am ET
MiniMed™ 780G system demonstrates superiority over multiple daily injections with CGM for type 1 diabetes management at one-year in ADAPT study
A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetes 
Feb 24, 2023 10:00 am ET
MiniMed™ 780G system demonstrates superiority over multiple daily injections with CGM for type 1 diabetes management at one-year in ADAPT study
A second randomized controlled trial sponsored by JDRF also demonstrates superiority of automated insulin pump as first-in-line therapy for children with type 1 diabetes 
Feb 21, 2023 05:45 am ET
Medtronic reports third quarter fiscal 2023 financial results
Delivers top and bottom line ahead of expectations, with strength in Cardiovascular and Neuroscience portfolios
Feb 17, 2023 07:30 am ET
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
EV-ICD defibrillation lead placed outside of heart and veins, preserving vasculature
Feb 14, 2023 09:05 am ET
Medtronic to announce financial results for its third quarter of fiscal year 2023
DUBLIN, Feb. 14, 2023 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2023 on Tuesday, February 21, 2023. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2023, which ended on Friday, January 27, 2023.
Feb 08, 2023 12:05 pm ET
Medtronic LINQ Insertable Cardiac Monitor detects 10 times more atrial fibrillation in ischemic stroke patients at three years compared to standard of care
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients
Feb 08, 2023 12:05 pm ET
Medtronic LINQ Insertable Cardiac Monitor detects 10 times more atrial fibrillation in ischemic stroke patients at three years compared to standard of care
ISC23: Late-breaking results from STROKE AF study reinforce importance of long-term continuous cardiac monitoring in ischemic stroke patients
Feb 01, 2023 09:57 am ET
Medtronic continues to make significant advances as an Inclusion, Diversity & Equity leader
Medtronic named to the 2023 Bloomberg Gender-Equality Index (GEI) the same week the company publishes its Global Inclusion, Diversity & Equity 2022 Annual Report
Feb 01, 2023 09:57 am ET
Medtronic continues to make significant advances as an Inclusion, Diversity & Equity leader
Medtronic named to the 2023 Bloomberg Gender-Equality Index (GEI) the same week the company publishes its Global Inclusion, Diversity & Equity 2022 Annual Report
Jan 25, 2023 06:20 pm ET
Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation
DUBLIN, Jan. 25, 2023 /CNW/ -- Medtronic plc (NYSE:MDT) recently became aware that TRC Capital Investment Corporation (TRC) has made an unsolicited mini-tender offer to purchase up to 1,500,000 Medtronic ordinary shares, representing approximately 0.1% of the company's outstanding ordinary shares. TRC's offer price of $77.25 per share in cash is approximately 4.5% lower than the $80.91 closing price of Medtronic ordinary shares on January 20, 2023, the last closing price prior to commencement of the offer.
Jan 25, 2023 06:20 pm ET
Medtronic recommends rejection of below-market mini-tender offer by TRC Capital Investment Corporation
DUBLIN, Jan. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) recently became aware that TRC Capital Investment Corporation (TRC) has made an unsolicited mini-tender offer to purchase up to 1,500,000 Medtronic ordinary shares, representing approximately 0.1% of the company's outstanding ordinary shares. TRC's offer price of $77.25 per share in cash is approximately 4.5% lower than the $80.91 closing price of Medtronic ordinary shares on January 20, 2023, the last closing price prior to commencement of the offer.
Jan 10, 2023 09:42 am ET
Medtronic named one of America's Most JUST Companies by JUST Capital and CNBC
The JUST 100 is the only ranking that recognizes companies doing right by all their stakeholders as defined by the American public
Dec 19, 2022 12:15 pm ET
Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
DUBLIN, Dec. 19, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 41st annual J.P. Morgan healthcare conference.
Dec 15, 2022 05:45 am ET
Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system
Expand URO is a prospective, multi-center, single-arm study to evaluate the safety and performance of the Hugo™ RAS system for urologic procedures
Dec 15, 2022 05:45 am ET
Medtronic announces first patient enrolled in U.S. clinical trial for Hugo™ robotic-assisted surgery system
Expand URO is a prospective, multi-center, single-arm study to evaluate the safety and performance of the Hugo™ RAS system for urologic procedures
Dec 14, 2022 08:05 am ET
Medtronic named as a leading sustainability company
Strong environmental, social, and governance (ESG) management and performance result in continued inclusion on the Dow Jones Sustainability World Index
Dec 08, 2022 03:15 pm ET
Medtronic announces cash dividend for third quarter of fiscal year 2023
DUBLIN, Dec. 8, 2022 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 8, 2022, approved the fiscal year 2023 third quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 45 consecutive years. The dividend is payable on January 13, 2023, to shareholders of record at the close
Dec 08, 2022 03:15 pm ET
Medtronic announces cash dividend for third quarter of fiscal year 2023
DUBLIN, Dec. 8, 2022 /CNW/ -- The board of directors of Medtronic plc (NYSE:MDT) on Thursday, December 8, 2022, approved the fiscal year 2023 third quarter cash dividend of $0.68 per ordinary share, representing an 8% increase over the prior year. This quarterly declaration is consistent with the dividend announcement made by the company in May 2022. Medtronic is a constituent of the S&P 500 Dividend Aristocrats index, having increased its annual dividend payment for the past 45 consecutive years. The dividend is payable on January 13, 2023, to shareholders of record at the close of busi
Dec 05, 2022 07:00 am ET
Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patients with atrial fibrillation
SPHERE Per-AF will determine the safety and effectiveness of the Sphere-9 cardiac ablation and mapping catheter with the Affera mapping and navigation system
Dec 05, 2022 07:00 am ET
Medtronic completes enrollment in pivotal trial evaluating first-of-its-kind pulsed field ablation catheter for patients with atrial fibrillation
SPHERE Per-AF will determine the safety and effectiveness of the Sphere-9 cardiac ablation and mapping catheter with the Affera mapping and navigation system
Nov 23, 2022 09:05 am ET
Medtronic executives to speak at the Evercore ISI 5th annual HealthCONx conference
DUBLIN, Nov. 23, 2022 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the Evercore ISI 5th annual HealthCONx conference on Tuesday, November 29, 2022. 
Nov 23, 2022 09:05 am ET
Medtronic executives to speak at the Evercore ISI 5th annual HealthCONx conference
DUBLIN, Nov. 23, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the Evercore ISI 5th annual HealthCONx conference on Tuesday, November 29, 2022. 
Nov 22, 2022 05:45 am ET
Medtronic reports second quarter fiscal 2023 financial results
Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes
Nov 22, 2022 05:45 am ET
Medtronic reports second quarter fiscal 2023 financial results
Earnings delivered despite slower market procedure volume and supply recovery; Growth driven by TAVR, Pacing, U.S. Core Spine, and International Diabetes
Nov 15, 2022 08:15 am ET
Medtronic to announce financial results for its second quarter of fiscal year 2023
DUBLIN, Nov. 15, 2022 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2023 on Tuesday, November 22, 2022. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2023, which ended on Friday, October 28, 2022.
Nov 15, 2022 08:15 am ET
Medtronic to announce financial results for its second quarter of fiscal year 2023
DUBLIN, Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2023 on Tuesday, November 22, 2022. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2023, which ended on Friday, October 28, 2022.
Nov 15, 2022 04:30 am ET
Medtronic Launches World's First and Only Infusion Set for Insulin Pumps that Doubles Wear Time up to 7 days in U.S.
Annual costs savings of insulin of up to 25% and plastic waste reduction of up to 50% with Medtronic Extended infusion set
Nov 09, 2022 05:30 pm ET
Nov 08, 2022 11:50 am ET
Cloud DX Announces Consortium to Advance Affordable Hospital-Level Care at Home
KITCHENER, ON / ACCESSWIRE / November 8, 2022 / Cloud DX (TSXV:CDX)(OTC:CDXFF), a leading digital health platform, today announced $5.2 million CAD of co-investment from the Digital Supercluster, through Innovation, Science and Economic Development Canada to create the Continuous Connected Patient Care (CCPC) digital platform. Continuous remote monitoring of recently discharged patients is expected to improve patient outcomes and free up badly needed hospital resources.
Nov 07, 2022 03:38 pm ET
SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other SPYRAL HTN renal denervation trials
DUBLIN and CHICAGO, Nov. 7, 2022 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The data were presented today as Late-Breaking Clinical Science at the American Heart Association (AHA) Scientific Sessions 2022. With this news, Medtronic has submitted the final module of the Symplicity Spyral™ Premarket Approval (PMA) package to the U.S. Food and Drug Administration (FDA) for review and approval.
Nov 07, 2022 03:38 pm ET
SPYRAL HTN-ON MED study demonstrates meaningful clinical benefits consistent with other SPYRAL HTN renal denervation trials
DUBLIN and CHICAGO, Nov. 7, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the six-month results from the full cohort of the SPYRAL HTN-ON MED clinical trial. The data were presented today as Late-Breaking Clinical Science at the American Heart Association (AHA) Scientific Sessions 2022. With this news, Medtronic has submitted the final module of the Symplicity Spyral™ Premarket Approval (PMA) package to the U.S. Food and Drug Administration (FDA) for review and approval.
Nov 07, 2022 02:49 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic Plc - MDT
Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“Medtronic” or the “Company”) (NYSE: MDT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Nov 07, 2022 11:00 am ET
Deadline Alert: Medtronic plc (MDT) Class Action - Bronstein, Gewirtz & Grossman, LLC, A Prominent Firm, Reminds Shareholders of Last Few Hours to Actively Participate
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Medtronic plc (“Medtronic” or the “Company”) (NYSE: MDT) and certain of its officers, on behalf of all persons and entities that purchased, or otherwise acquired Medtronic securities between June 8, 2019, and May 25, 2022, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site:
Nov 07, 2022 10:45 am ET
MedTech Market Leaders Share Their Long-Term Business Strategy at CECP's CEO Investor Forum @ The MedTech Conference
Three CEOs representing over $372 billion in market capitalization set the context for the future engaging with institutional investors
Nov 07, 2022 10:10 am ET
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Medtronic plc with Losses of $500,000 to Contact the Firm
LOS ANGELES, Nov. 7, 2022 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Medtronic plc ("Medtronic" or "the Company") (NYSE: MDT) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Nov 07, 2022 04:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Medtronic Investors of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Attention Medtronic plc ("Medtronic") (NYSE: MDT) shareholders:
Nov 06, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Bed Bath & Beyond, Sema4, Medtronic, and Palantir and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bed Bath & Beyond, Inc. (NASDAQ: BBBY), Sema4 Holdings Corp. (NASDAQ: SMFR,...
Nov 04, 2022 10:50 pm ET
MEDTRONIC 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Medtronic
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against Medtronic plc (NYSE: MDT), if they purchased the Company’s shares between June 8, 2019, and May 25, 2022, inclusive (the “Class Period”). This action is pending in the United States District Court for the District of Minnesota.
Nov 04, 2022 11:43 am ET
SMFR, MDT & TWTR Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Nov 04, 2022 05:45 am ET
MDT SHAREHOLDER ALERT: Jakubowitz Law Reminds Medtronic Shareholders of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Nov. 4, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Medtronic plc (NYSE: MDT).
Nov 03, 2022 05:45 am ET
MDT LAWSUIT ALERT: Levi & Korsinsky Notifies Medtronic plc Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Nov. 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) of a class action securities lawsuit.
Nov 02, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Medtronic plc - MDT
CEDARHURST, N.Y., Nov. 2, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Medtronic plc (NYSE: MDT), if they purchased the Company's shares between June 8, 2019, and May 25, 2022, inclusive (the "Class Period"). Shareholders have until November 7, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Nov 02, 2022 08:20 am ET
Medtronic Launches New Platform To Accelerate Innovation in Stroke Care
NORTHAMPTON, UK / ACCESSWIRE / November 2, 2022 / Medtronic Stroke is a leading cause of death and disability around the world, but only a fraction of people who suffer a stroke get treatment in time. Medtronic is taking bold new steps to change that by launching the Medtronic Neurovascular Co-Lab™, an innovation process and platform for new ideas in the treatment of stroke care.
Nov 02, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Medtronic plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2022 - (NYSE: MDT)
NEW YORK, Nov. 2, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medtronic plc.
Nov 01, 2022 10:52 pm ET
MEDTRONIC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against...
Nov 01, 2022 05:45 am ET
MDT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 7, 2022 in the Class Action Filed on Behalf of Medtronic plc Shareholders
NEW YORK, Nov. 1, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Medtronic plc (NYSE: MDT) alleging that the Company violated federal securities laws.
Oct 31, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kohl’s Corporation (NYSE: KSS), Bed Bath & Beyond, Inc. (NASDAQ: BBBY), Sema4...
Oct 31, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Medtronic Investors of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Oct. 31, 2022 /PRNewswire/ -- Attention Medtronic plc ("Medtronic") (NYSE: MDT) shareholders:
Oct 30, 2022 05:07 pm ET
MDT INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Medtronic plc Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – MDT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Medtronic plc (NYSE: MDT) between June 8, 2019 and May 25, 2022, both dates inclusive (the “Class Period”), of the important November 7, 2022 lead plaintiff...
Oct 30, 2022 03:04 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic Plc - MDT
Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“”Medtronic” or the “Company”) (NYSE: MDT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Oct 28, 2022 10:50 pm ET
MEDTRONIC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
NEW ORLEANS, Oct. 28, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against Medtronic plc (NYSE: MDT), if they purchased the Company's shares between June 8, 2019, and May 25, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Minnesota.
Oct 28, 2022 06:18 pm ET
ROSEN, A RANKED AND LEADING FIRM, Encourages Medtronic plc Investors to Secure Counsel Before Important November 7 Deadline in Securities Class Action – MDT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Medtronic plc (NYSE: MDT) between June 8, 2019 and May 25, 2022, both dates inclusive (the “Class Period”), of the important November 7, 2022 lead plaintiff deadline.
Oct 28, 2022 05:45 am ET
MDT SHAREHOLDER ALERT: Jakubowitz Law Reminds Medtronic Shareholders of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Oct. 28, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Medtronic plc (NYSE: MDT).
Oct 27, 2022 12:00 pm ET
Medtronic Podcast: Why We Need To Stop Ignoring the Equivalent of 747s Crashing Daily and Expand Lung Cancer Screening
NORTHAMPTON, MA / ACCESSWIRE / October 27, 2022 / This episode shines a light on lung cancer, a deadly killer that isn't getting the attention it deserves. Dr. William Mayfield, WellStar Health System medical director, and former chief surgical officer says lung cancer kills thousands of people every day - more than most other cancers combined - but isn't screened for as aggressively. Drawing motivation from a personal loss to lung cancer, Emily Elswick, vice president in the Office of the CEO and former vice president and general manager of Lung Health and Visualization, says
Oct 27, 2022 05:45 am ET
MDT LAWSUIT ALERT: Levi & Korsinsky Notifies Medtronic plc Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 27, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) of a class action securities lawsuit.
Oct 26, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Medtronic plc - MDT
The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Medtronic plc (NYSE: MDT), if they purchased the Company’s shares between June 8, 2019, and May 25, 2022, inclusive (the “Class Period”). Shareholders...
Oct 26, 2022 10:50 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic Plc - MDT
NEW YORK, Oct. 26, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc ("Medtronic" or the "Company") (NYSE: MDT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 26, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Kohl’s, Bed Bath & Beyond, Sema4, and Medtronic and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Kohl’s Corporation (NYSE: KSS), Bed Bath & Beyond, Inc. (NASDAQ: BBBY), Sema4...
Oct 26, 2022 09:00 am ET
Announcing the launch of Medtronic Neurovascular Co-Lab™ Platform to accelerate innovation in stroke treatment
New Medtronic Neurovascular Co-Lab™ Platform drives collaboration and connections among start-ups, physicians, and institutions; aims to improve stroke treatment and access for patients worldwide
Oct 25, 2022 10:59 pm ET
MEDTRONIC HOLDINGS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Medtronic plc - MDT
ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against Medtronic plc (NYSE: MDT), if they purchased the Company’s...
Oct 25, 2022 11:41 am ET
SMFR, MDT & TWTR Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 25, 2022 05:45 am ET
MDT ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of November 7, 2022 in the Class Action Filed on Behalf of Medtronic plc Shareholders
NEW YORK, Oct. 25, 2022 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Medtronic plc (NYSE: MDT) alleging that the Company violated federal securities laws.
Oct 24, 2022 10:31 pm ET
Medtronic chairman and CEO Geoff Martha to speak at the CECP's CEO Investor Forum
DUBLIN, Oct. 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the Chief Executives for Corporate Purpose's (CECP's) 10th CEO Investor Forum held at AdvaMed's 2022 MedTech Conference on Tuesday, October 25, 2022, in Boston, MA.
Oct 24, 2022 08:10 am ET
Diversifying the Medtronic Sales Force
NORTHAMPTON, MA / ACCESSWIRE / October 24, 2022 / When Ursula Douglas started working for Medtronic in 2015, she remembers being the only woman on her sales team and one of the few women of color working as a Medtronic senior interventional sales representative. In fact, the U.S. sales force was one of the least diverse employee groups for Medtronic.
Oct 24, 2022 06:45 am ET
Medtronic announces intention to separate its combined Patient Monitoring and Respiratory Interventions businesses
Separation of the combined Patient Monitoring and Respiratory Interventions businesses ("NewCo") expected to better position both NewCo and Medtronic for long-term success and value creation
Oct 24, 2022 06:45 am ET
Medtronic announces intention to separate its combined Patient Monitoring and Respiratory Interventions businesses
Separation of the combined Patient Monitoring and Respiratory Interventions businesses ("NewCo") expected to better position both NewCo and Medtronic for long-term success and value creation
Oct 24, 2022 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Medtronic Investors of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Oct. 24, 2022 /PRNewswire/ -- Attention Medtronic plc ("Medtronic") (NYSE: MDT) shareholders:
Oct 23, 2022 05:15 pm ET
ROSEN, LEADING INVESTOR COUNSEL, Encourages Medtronic plc Investors with Losses Over $100K to Secure Counsel Before Important Deadline in Securities Class Action – MDT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Medtronic plc (NYSE: MDT) between June 8, 2019 and May 25, 2022, both dates inclusive (the “Class Period”), of the important November 7, 2022 lead plaintiff...
Oct 22, 2022 04:21 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic Plc - MDT
Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (“”Medtronic” or the “Company”) (NYSE: MDT).   Such investors are advised to contact Robert S. Willoughby at  [email protected] or 888-476-6529, ext. 7980. The...
Oct 21, 2022 10:50 pm ET
MEDTRONIC HOLDINGS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Medtronic plc - MDT
NEW ORLEANS, Oct. 21, 2022 /PRNewswire/ -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against Medtronic plc (NYSE: MDT), if they purchased the Company's shares between June 8, 2019, and May 25, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Minnesota.
Oct 21, 2022 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Medtronic, Palantir, Fulgent, and Yatsen and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Medtronic PLC (NYSE: MDT), Palantir Technologies, Inc. (NYSE: PLTR), Fulgent...
Oct 21, 2022 05:55 pm ET
Out & Equal Honors Medtronic PRIDE
NORTHAMPTON, MA / ACCESSWIRE / October 21, 2022 / Medtronic
Oct 21, 2022 05:45 am ET
MDT SHAREHOLDER ALERT: Jakubowitz Law Reminds Medtronic Shareholders of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Medtronic plc (NYSE: MDT).
Oct 20, 2022 05:45 am ET
MDT LAWSUIT ALERT: Levi & Korsinsky Notifies Medtronic plc Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, Oct. 20, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Medtronic plc ("Medtronic" or the "Company") (NYSE: MDT) of a class action securities lawsuit.
Oct 19, 2022 10:50 pm ET
FILING DEADLINE--Kuznicki Law PLLC Announces Class Action on Behalf of Shareholders of Medtronic plc - MDT
CEDARHURST, N.Y., Oct. 19, 2022 /PRNewswire/ -- The securities litigation law firm of Kuznicki Law PLLC issues this alert to shareholders of Medtronic plc (NYSE: MDT), if they purchased the Company's shares between June 8, 2019, and May 25, 2022, inclusive (the "Class Period"). Shareholders have until November 7, 2022 to file lead plaintiff applications in the securities class action lawsuit.
Oct 19, 2022 01:40 pm ET
Carol Surface Named World's Top Chief Human Resources Officer
NORTHAMPTON, MA / ACCESSWIRE / October 19, 2022 / Medtronic Executive Vice President and Chief Human Resources Officer Carol Surface is the top CHRO in the world for 2022, according to N2 Growth, a global executive search and leadership advisory firm.
Oct 19, 2022 08:30 am ET
Medtronic expands global access to the benefits of robotic-assisted surgery
Hugo™ robotic-assisted surgery system regulatory approval in Japan provides access to third largest robotics market in the world while general surgery approval in the EU and Canada open fast-growing hernia specialty
Oct 19, 2022 08:30 am ET
Medtronic expands global access to the benefits of robotic-assisted surgery
Hugo™ robotic-assisted surgery system regulatory approval in Japan provides access to third largest robotics market in the world while general surgery approval in the EU and Canada open fast-growing hernia specialty
Oct 19, 2022 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Medtronic plc of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2022 - (NYSE: MDT)
NEW YORK, Oct. 19, 2022 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Medtronic plc.
Oct 19, 2022 12:41 am ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Medtronic Plc - MDT
NEW YORK, Oct. 19, 2022 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Medtronic Plc (""Medtronic" or the "Company") (NYSE: MDT). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Oct 18, 2022 10:53 pm ET
MEDTRONIC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against...
Oct 18, 2022 03:25 pm ET
ROSEN, LEADING INVESTOR COUNSEL, Encourages Medtronic plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MDT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Medtronic plc (NYSE: MDT) between June 8, 2019 and May 25, 2022, both dates inclusive (the “Class Period”), of the important November 7, 2022 lead plaintiff...
Oct 18, 2022 08:10 am ET
Making Investments in the Next Generation
NORTHAMPTON, MA / ACCESSWIRE / October 18, 2022 / The journey to New York City was a first for many of the students who traveled to the 2022 Thurgood Marshall College Fund (TMCF) Leadership Institute in Times Square last month. Jordyn Harris was among them. The recent graduate of Delaware State University - one of the historically Black colleges and universities (HBCUs) - was there as not just an alum, but as a recent Medtronic recruit.
Oct 18, 2022 08:00 am ET
Medtronic leverages data science to launch first-of-its-kind personalized insights program for people living with diabetes
DUBLIN, Oct. 18, 2022 /PRNewswire/ -- Medtronic plc, the global leader in medical technology, is introducing a new program called My Insights exclusively made for individuals using the MiniMed™ 770G system. Using an individual's data, My Insights relies on the power of data science to provide personalized tips, trends, and reminders that customers can use to help with their diabetes management goals. The My Insights personalized recommendations are shared via a monthly email with educational content that is most relevant based on what an individual may currently be experiencing.  
Oct 17, 2022 09:00 am ET
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Medtronic "Conduction System Pacing" Expanded Indication Now Includes Left Bundle Branch Area Pacing in Addition to His-Bundle Pacing for Patients with Slow Heart Rates
Oct 16, 2022 11:37 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Sema4, Medtronic, Palantir, and Fulgent and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Sema4 Holdings Corp. (NASDAQ: SMFR, SMFRW), Medtronic PLC (NYSE: MDT), Palantir...
Oct 14, 2022 10:50 pm ET
MEDTRONIC SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
NEW ORLEANS, Oct. 14, 2022 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until November 7, 2022 to file lead plaintiff applications in a securities class action lawsuit against Medtronic plc (NYSE: MDT), if they purchased the Company's shares between June 8, 2019, and May 25, 2022, inclusive (the "Class Period"). This action is pending in the United States District Court for the District of Minnesota.
Oct 14, 2022 09:06 pm ET
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Medtronic plc Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – MDT
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the stock of Medtronic plc (NYSE: MDT) between June 8, 2019 and May 25, 2022, both dates inclusive (the “Class Period”), of the important November 7, 2022 lead plaintiff...
Oct 14, 2022 11:39 am ET
SMFR, MDT & TWTR Class Action Deadlines: Bronstein, Gewirtz & Grossman, LLC, A Successful Firm, Reminds Investors of Deadlines and to Actively Participate
Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may...
Oct 14, 2022 11:26 am ET
Medtronic to webcast renal denervation investor & analyst briefing on November 7
DUBLIN, Oct. 14, 2022 /CNW/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its Medtronic Coronary and Renal Denervation business during the American Heart Association annual scientific sessions (AHA 2022) on Monday, November 7, 2022, at 5 p.m. CST. The webcast will feature remarks from Medtronic Coronary and Renal Denervation management, including comments on the 6-month results from the SPYRAL HTN-ON MED Randomized Trial (ON MED). These data will be presented as part of a late-breaking science se
Oct 14, 2022 11:26 am ET
Medtronic to webcast renal denervation investor & analyst briefing on November 7
DUBLIN, Oct. 14, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the company will host a webcast to provide an update on its Medtronic Coronary and Renal Denervation business during the American Heart Association annual scientific sessions (AHA 2022) on Monday, November 7, 2022, at 5 p.m. CST. The webcast will feature remarks from Medtronic Coronary and Renal Denervation management, including comments on the 6-month results from the SPYRAL HTN-ON MED Randomized Trial (ON MED). These data will be presented as part of a late-breaking sci
Oct 14, 2022 05:45 am ET
MDT SHAREHOLDER ALERT: Jakubowitz Law Reminds Medtronic Shareholders of a Lead Plaintiff Deadline of November 7, 2022
NEW YORK, Oct. 14, 2022 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Medtronic plc (NYSE: MDT).
Oct 13, 2022 10:00 am ET
Fortune and Great Place to Work(R) Name Medtronic One of the ‘World’s Best Workplaces(TM)’ in 2022
DUBLIN, IRELAND / ACCESSWIRE / October 13, 2022 / Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that Great Place to Work® and Fortune magazine have honored Medtronic as one of the 25 global companies named to the World's Best Workplaces™ in 2022.
Oct 13, 2022 09:15 am ET
Fortune and Great Place to Work® Name Medtronic one of the 'World's Best Workplaces™' in 2022
This is the second notable recognition the company has received this week, following being named to the Fortune 2022 'Change the World' list

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.